Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed CFO
Inv. presentation
Quarterly results
|
|
Cytosorbents Corp (CTSO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
4
| BATOR MICHAEL G. (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 1,000 shares
@ $3.23, valued at
$3.2k
Bought 1,000 shares
@ $3.2, valued at
$3.2k
Bought 1,000 shares
@ $3.15, valued at
$3.2k
|
|
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2023 |
4
| BLOCH KATHLEEN P. (Interim CFO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 5,000 shares
@ $3.0596, valued at
$15.3k
Bought 2,000 shares
@ $3.125, valued at
$6.3k
Bought 3,000 shares
@ $3.1699, valued at
$9.5k
|
|
| 04/05/2023 |
4
| Capponi Vincent (See Remarks) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Exercised 10,000 options to buy
@ $2.875, valued at
$28.8k
|
|
| 04/05/2023 |
4
| Chan Phillip P. (CEO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Exercised 30,500 options to buy
@ $2.875, valued at
$87.7k
|
|
| 03/01/2023 |
4
| Sobel Alan D. (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Gifted 2,000 shares
@ $0
Gifted 2,000 shares
@ $0 |
|
| 02/08/2023 |
4
| Kraus Al (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Exercised 12,000 options to buy
@ $2.65, valued at
$31.8k
|
|
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2022 |
4
| Chan Phillip P. (CEO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 35,000 shares
@ $1.7, valued at
$59.5k
|
|
| 08/26/2022 |
4
| Kim Jiny (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 1,000 shares
@ $1.91, valued at
$1.9k
|
|
| 08/12/2022 |
4
| Sobel Alan D. (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 18,975 options to buy
@ $1.95, valued at
$37k
|
|
| 08/12/2022 |
4
| Kim Jiny (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 18,975 options to buy
@ $1.95, valued at
$37k
|
|
| 08/12/2022 |
4
| Jones Edward Raymond (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 18,975 options to buy
@ $1.95, valued at
$37k
|
|
| 08/12/2022 |
4
| BATOR MICHAEL G. (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 18,975 options to buy
@ $1.95, valued at
$37k
|
|
| 08/12/2022 |
4
| Kraus Al (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 37,950 options to buy
@ $1.95, valued at
$74k
|
|
| 08/12/2022 |
4
| Deliargyris Efthymios (Chief Medical Officer) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 55,000 shares
@ $0
Granted 52,000 shares
@ $0
Granted 74,000 options to buy
@ $1.95, valued at
$144.3k
Granted 300,000 options to buy
@ $1.95, valued at
$585k
|
|
| 08/12/2022 |
4
| Capponi Vincent (President and COO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 69,000 shares
@ $0
Granted 86,000 options to buy
@ $1.95, valued at
$167.7k
Granted 250,000 options to buy
@ $1.95, valued at
$487.5k
|
|
| 08/12/2022 |
4
| BLOCH KATHLEEN P. (CFO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 55,500 shares
@ $0
Granted 75,000 options to buy
@ $1.95, valued at
$146.3k
Granted 215,000 options to buy
@ $1.95, valued at
$419.3k
|
|
| 08/12/2022 |
4
| Chan Phillip P. (CEO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Granted 79,000 shares
@ $0
Granted 106,000 options to buy
@ $1.95, valued at
$206.7k
Granted 240,000 options to buy
@ $1.95, valued at
$468k
|
|
| 06/22/2022 |
4
| Capponi Vincent (President and COO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 2,000 shares
@ $1.8, valued at
$3.6k
|
|
| 06/21/2022 |
4
| Capponi Vincent (See Remarks) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 3,000 shares
@ $2, valued at
$6k
|
|
| 06/21/2022 |
4
| Chan Phillip P. (CEO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 2,221 shares
@ $1.85, valued at
$4.1k
|
|
| 06/10/2022 |
4
| Chan Phillip P. (CEO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 16,000 shares
@ $2.174, valued at
$34.8k
|
|
| 06/06/2022 |
4
| BLOCH KATHLEEN P. (CFO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 8,700 shares
@ $1.8999, valued at
$16.5k
|
|
| 05/25/2022 |
4
| Capponi Vincent (President and COO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 1,574 shares
@ $2.04, valued at
$3.2k
Bought 299 shares
@ $2.025, valued at
$605.5
Bought 3,127 shares
@ $2.03, valued at
$6.3k
|
|
| 05/19/2022 |
4
| BATOR MICHAEL G. (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 2,000 shares
@ $2.18, valued at
$4.4k
Bought 2,000 shares
@ $2.2, valued at
$4.4k
Bought 1,000 shares
@ $2.21, valued at
$2.2k
|
|
|
|
|